Biomedpartners

About The Fund

BioMedPartners is a leading venture capital firm based in Basel, Switzerland specializing in the healthcare sector. With a primary focus on the European market, they have a diversified portfolio encompassing several sub-sectors within healthcare including IT and TMT, BioTech, FinTech and Financial Services, Medical Devices and Hospital Services, Investment Management, Life Science, and Oncology. Their investment strategy revolves around the development of new technologies and treatments with the potential to significantly improve patient health outcomes.Their approach is to partner with companies at various stages of development, providing capital, strategic guidance, and access to a broad network of industry experts. BioMedPartners is known for their active role in managing investments and assisting entrepreneurial teams in realizing their business objectives. Over the years, they have played a crucial role in the advancement of numerous innovative therapies, medical devices, and services that have the potential to revolutionize the healthcare industry.For entities interested in the divestment activities of earlier funds, including BioMedInvest I to III, they are directed to get in touch with BioMedPartners. These early funds are indicative of their long-standing presence and success within the investment landscape. For new investment opportunities, entities and individuals should refer to BiomedVC, specifically BMI IV onwards. Through their various funds, BioMedPartners has demonstrated a commitment to fostering growth in transformative healthcare companies, striving to generate substantial returns for their investors while contributing to global health advancements.